References
- Friedland RP. Lipid metabolism, epidemiology, and the mechanisms of Alzheimer's disease. Ann N Y Acad Sci 2002;977:387–90
- Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123–9
- Ahlborg HG, Johnell 0, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med 2003;349:327–34
- Paoletti R, Wenger NK. Review of the Interna-tional Position Paper on Women's Health and Menopause: a comprehensive approach. Circu-lation 2003;107:1336–9
- Robinson D, Cardozo L. The menopause and HRT. Urogenital effects of hormone therapy. Best Pract Res Clin Endocrinol Metab 2003;17:91–104
- Short M. Menopause, mood and management. Climacteric 2003;6(Suppl 2):33–6
- North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11–33
- North American Menopause Society. Role of progestogen in hormone therapy for postmeno-pausal women: position statement of The North American Menopause Society. Menopause 2003;10:113–32
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal re-sults from the Women's Health Initiative randomizedcontrolledtrial.JAMA2002;288:321–33
- Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673–84
- Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postme- nopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243–53
- Calaf i Alsina J. Benefits of hormone replace-ment therapy — overview and update. Int J Fertil Womens Med 1997;42(Suppl 2):329–46
- Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy iso-flavones for menopausal women. Public Health Nutr 1999;2:489–504
- North American Menopause Society. The role of isoflavones in menopausal health: consensus opinion of The North American Menopause Society. Menopause 2000;7:215–29
- Fitzpatrick LA. Soy isoflavones: hope or hype? Maturitas 2003;44(Suppl 1):S21–9
- Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplemen-tation in a sample of postmenopausal women. Climacteric 2002;5:374–82
- Hilliam M. Functional foods: the western con-sumer viewpoint. Nutr Rev 1996;54:5189–94
- Sadler MJ, Saltmarsh M. Functional Foods: the Consumer, the Product and the Evidence. London: The Royal Society of Chemistry In-formation Services, 1998
- Gilbert LC. The functional food trend: what's next and what Americans think about eggs. J Am Coll Nutr 2000;19:507–125
- International Food Information Council Foun-dation. Functional foods: attitudinal research, quantitative and qualitative summary. In Func-tional Foods: Attitudinal Research. Washington, DC: International Food Information Council Foundation, 2000
- Messina M, Messina V. Soyfoods, soybean isoflavones, and bone health: a brief overview. J Ren Nutr 2000;10:63–8
- Albertazzi P. Purified phytoestrogens in post-menopausal bone health: is there a role for genistein? Climacteric 2002;5:190–6
- Messina MJ. Soy foods and soybean isoflavones and menopausal health. Nutr Clin Care 2002;5:272–82
- Demonty I, Lamarche B, Jones PJ. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 2003;61:189–203
- Hermansen K, Dinesen B, Hoie LH, Morgen-stern E, Gruenwald J. Effects of soy and other natural products on LDL : HDL ratio and other lipid parameters: a literature review. Adv Ther 2003;20:50–78
- Wuttke W, Jarry H, Becker T, et al. Phytoestro-gens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2003;44(Suppl 1):S9–20
- Kreijkamp-Kaspers S, Kok L, der Schouw YT, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomizedcontrolledtrial.JAMA2004;292:65–74
- Sloan AE. The top 10 functional food trends 2004. Food Technology 2004;58:28
- O'Doherty Jensen K, Holm L. Preferences, quantities and concerns: socio-cultural perspec-tives on the gendered consumption of foods. Eur J Clin Nutr 1999;53:351–9
- Bech-Larsen T, Grunert KG. The perceived healthiness of functional foods. A conjoint study of Danish, Finnish and American consumers' perception of functional foods. Appetite 2003;40:9–14
- Flight I, Leppard P, Cox DN. Food neophobia and associations with cultural diversity and socio-economic status amongst rural and urban Australian adolescents. Appetite 2003;41:51–9
- Menrad K. Market and marketing of functional food in Europe. J Food Engineering 2003;56:181–8
- Kirk SF, Cade JE, Barrett JH, Conner M. Diet and lifestyle characteristics associated with diet-ary supplement use in women. Public Health Nutr 1999;2:69–73
- Greger JL. Dietary supplement use: consumer characteristics and interests. J Nutr 2001; 131:1339–43S
- de Jong N, Ocke MC, Branderhorst HA, Friele R. Demographic and lifestyle characteristics of functional food consumers and dietary supplement users. Br J Nutr 2003;89: 273–81
- Grunert KGB-L, Tino; Bredahl, Lone. Three issues in consumer quality perception and acceptance of dairy products. Int Dairy J 2000;10:575–84
- Bliimel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone replacement therapy on postmenopausal women's health perceptions. Menopause 2003;10:235–40
- Aber CS, Arathuzik D, Righter AR. Women's perceptions and concerns about menopause. Clin Excell Nurse Pract 1998;2:232–8
- Kang HJ, Ansbacher R, Hammoud MM. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 2002; 79:195–207
- Worsley ACD. Dietary supplementers dietary descriptions, lifestyles and personal values. Ecol Food Nutr 1988;22:139–56
- Gilbert L. Marketing functional foods: how to reach your target audience. AgBioForum 2000; 3:20–38
- Peters HW, Westendorp IC, Hak AE, et al. Menopausal status and risk factors for cardio-vascular disease. J Intern Med 1999;246:521–8
- Do KA, Green A, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol 2000;151:584–93
- World Health Organization. European Health for all — database. Copenhagen, Denmark: World Health Organization, 2002
- Blumel JE, Tacla X, Brandt A, Gramegna G, Estartus A. [Knowledge and beliefs of the effect of menopause and estrogenic therapy on health. Study in women attending the Barros Luco-Trudeau Hospital]. Rev Chil Obstet Ginecol 1994;59:10–16